Details

Autor(en) / Beteiligte

• Ngomtcho, Sen Claudine Henriette
• Akenji, Blaise Mboringong
• Tchio-Nighie, Ketina Hirma
• Fokam, Joseph
• Guenou, Etienne
• Nsa'Amang Eyebe, Carolle
• Nzegni Kamkoum, Yvan Junior
• Ntale Tchoffo, Valdex Derick
• Buh Nkum, Collins
• Tchoudjin Paho, Hervé Christian
• Ebogo, Yvette Marie Solange
• Nanfak, Aude
• Maidadi-Foudi, Martin
• Fouda, Crescence
• Andigema, Angyiba Serge
• Nsah Bongdze-Em, Lilian
• Nfor, Beri Nadin
• Torimiro, Judith
• Zoung-Kanyi Bissek, Anne Cécile
• Noubom, Michel
• Assoumou Okomo, Marie Claire
• Ateudjieu, Jérôme
• Hossain, Ahmed

Titel

SARS-CoV-2 active infection and antibodies amongst health personnel during the outbreak in Cameroon: Strengthening the health system for response to future public health emergencies

Ist Teil von

• PloS one, 2024-05, Vol.19 (5), p.e0304477

Ort / Verlag

United States: Public Library of Science

Erscheinungsjahr

2024

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Health personnel (HP) are on the frontlines during response to public health emergencies like COVID-19. This risk of exposure suggests the need for safety in responding to any pandemic. Therefore, to ascertain the rate of SARS-CoV-2 infection and immunity, and their determinants amongst HP become relevant. A cross sectional health facility-based study was carried-out amongst HP in the Centre Region of Cameroon from 1st February to 30th June 2021. Characteristics and access to preventive tools were collected using face-to-face administered questionnaire. Nasopharyngeal swabs and whole blood were collected for PCR, IgG and IgM testing respectively. STATA version 17 software was used for data analysis. Determinants of COVID-19 infection were explored by estimating crude and adjusted Odd Ratio. Out of 510 HP reached, 458 were enrolled with mean age of 35 (±10) years. Thirty-four (7.4%) were PCR-positive to SARS-CoV-2 with 73.5% being clinicians versus 9 (26.4%) non-clinicians (p = 0.05). Sero-positivity to SARS-CoV-2 IgG/IgM was 40.2% (184/458), with 84.2% being clinicians versus 29 (15.8%) non-clinicians (p = 0.733). Amongst the 34 HP with PCR-positivity, 16 (47%) had no antibodies, while, 15 (44%) were IgG only. An estimate of HP (43.7%) had at least an evidence of PCR, IgG or IgM contact to COVID-19. Determinants of PCR-positivity was being clinical staff (AOR = 0.29, P = 0.039); and that of IgG/IgM were being non clinical staff (AOR = 0.41, p = 0.018) and regular use of face masks (AOR = 0.44, p = 0.001). HP trained on IPC (24%) were mainly from peripheral level (74.7%, p = 0.002). Active infections were within the range of pandemic control (<10%). However, around two-fifths of participants have had contact with the virus, indicating that HP remains a population at risk of COVID-19 and other similarly-transmitted epidemic prone diseases, and also an important source of transmission. There is need of vaccine to achieve protectiveness, and optimal response also requires capacity building to improve the health system when challenged by a future pandemic.